SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chiron

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
To: ali foughi who wrote (22)11/28/1996 2:44:00 AM
From: Spekulatius   of 23
 
Chiron Fundamentals:

You get them at:

www2.marketguide.com

I think Chiron is interesting below 20$ for bargain hunters. Chart does not look too bad, has stablilized at 18$. A big asset is that Ciba owns 49% of Chiron. Ciba will fusion with Sandoz to form Novartis, the biggest pharmaceutical company. Sooner or later, Novartis might buy Chiron.
In the short view, Chiron is under pressure. The betaseron (to treat MS) is under pressure from Biogens Avonex (which seems to be better) and the clinical trials on the herpes treatment showed not the results they hoped for. Some people on the other chiron board say that this co. has a very good product pipeline. I not so shure. Bought Genzyme lately. Looks much better and is cheaper!

I hope this helps!

Ralf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext